Dr Stephen Ahenkorah holds PhD in Biomedical Sciences (Radiopharmacy) and currently works as an associate research scientist at the radiology department of the University of Iowa. Prior to this position he was a postdoctoral fellow at KU Leuven, Belgium where he developed an agent called 3p-C-NETA-TATE for targeting neuroendocrine tumors in vivo.
Development of radiopharmaceuticals for cancer treatment
Editor
Doctor
The University of Iowa
Radiology
USA